Hk Inno.n Corporation

This study tests an experimental injection called IN-B00009 for weight loss in adults with obesity or overweight who do not have diabetes. About 300 participants will receive either the drug or a placebo to see how much weight they lose over 40 weeks. The goal is to find a safe a…

This study tests an experimental injection called IN-B00009 in adults with type 2 diabetes whose blood sugar is not well controlled by diet and exercise alone. About 110 participants will receive either the drug or a placebo for 24 weeks. The main goal is to see if the drug lower…

This study checks if two drugs, IN-M00007 and IN-R00007, are absorbed and processed the same way in the body. It involves 60 healthy adults aged 19 to 59. Each person takes a single dose of both drugs at different times, and researchers measure drug levels in the blood to compare…

This study looks at how a new tablet (IN-M00002) moves through the body when taken alone or with other drugs (tegoprazan and naproxen), and how food affects it. It involves 74 healthy adults aged 19 to 55. The goal is to gather safety and drug-level information, not to treat any …